Connect with us

National

India approves AstraZeneca vaccine as company still working on jab’s efficacy of at least 62% after disappointing trial results – RT

India has approved AstraZeneca’s Covid-19 jab for emergency use, despite trials showing its efficacy to be 62 percent with two full shots. AstraZeneca claims to…

Published

on

post featured image

India’s information minister, Prakash Javadekar, announced on Saturday that the coronavirus vaccine, designed by the British-Swedish drugmaker AstraZeneca in collaboration with the University of Oxford, had been approved by regulators a day earlier for emergency use. Formal approval by the Drugs Controller General of India is expected in the coming days.
The news came as India surpassed its 10 millionth case of Covid-19, and inched closer to 150,000 deaths. 
Also on rt.comArgentina 2nd to approve…

Click here to view the original article.

Safety Mate